Led by researchers at the University of Laval in Canada, the study found that mice with increased levels of cannabinoid ...

Researchers from Washington University School of Medicine and Stanford University have developed a compound that simulates a ...

The protein, called cannabinoid receptor type 1 (CB1), is part of the blood-brain barrier, the dynamic structure that protects the brain by regulating the passage of molecules between the ...

Evidence is stacking up about the influence of cannabinoids on cardiovascular disease, and newer, synthetic options are ...

NIH-Funded Research Team Engineers New Drug Targeting Pain Sensation Pathway with Implications for Chronic Pain Treatment ...

POTOMAC, MD / ACCESS Newswire / March 20, 2025 / IGC Pharma, Inc. ("IGC", or the "Company") (NYSE American:IGC) today ...

They bind to a receptor, called cannabinoid receptor one (CB1), on the surface of brain cells and on pain-sensing nerve cells throughout the body. Working with collaborators at Stanford University, co ...

Allied Market Research published a report, titled, "Cannabinoid Based Drug Discovery and Development Market by Receptor Target (CB1 Receptor, CB2 Receptor), by End User (Pharmaceutical Companies, ...

CB1 receptors are abundant in neurons, but they're also found in astrocytes, star-shaped cells allowing communication between the brain's blood vessels and neurons.

“The protein, called cannabinoid receptor type 1 (CB1), is part of the blood-brain barrier, the dynamic structure that protects the brain by regulating the passage of molecules between the blood ...

“The protein, called cannabinoid receptor type 1 (CB1), is part of the blood-brain barrier, the dynamic structure that protects the brain by regulating the passage of molecules between the blood ...